Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study

Next Previous
Trial Profile

The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Acute coronary syndromes; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms OPTIMIZE; OPTIMIZE IDE

Most Recent Events

  • 21 Mar 2023 Status changed from active, no longer recruiting to discontinued.
  • 18 Oct 2020 Results of imaging substudy presented at the 32nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
  • 18 Oct 2020 Results (n=1288) of prespecified analysis evaluating outcomes associated with radial and femoral access with intent to obtain a transradial indication presented at the 32nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top